Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
The bactericidal/permeability-increasing protein (BPI) of neutrophils and BPI fragments neutralize the effects of isolated Gram-negative bacterial lipopolysaccharides both in vitro and in vivo. Since endotoxin most commonly enters the host as constituents of invading Gram-negative bacteria, we raise...
Guardado en:
| Publicado en: | J Clin Invest |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Clinical Investigation
1992
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC329974/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1522221/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI115930 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
